Strategy Inc (formerly MicroStrategy Incorporated) is a Delaware-incorporated company headquartered in Tysons Corner, Virginia, operating both a business intelligence and analytics software segment and a large-scale bitcoin acquisition and treasury strategy. The company holds bitcoin as its primary asset, funded through equity issuance and preferred stock offerings, and has listed four series of perpetual preferred stock (STRF, STRC, STRK, STRD) alongside its Class A common stock (MSTR) on the Nasdaq Global Select Market. As of September 30, 2025, digital assets totaling $73.2 billion represented the dominant portion of the company's $73.6 billion in total assets.

What is MSTR's DredgeCap risk score?

DredgeCap's AI analysis rates MSTR at 6.2/10 on the risk scale — High risk. This score reflects dilution exposure, debt toxicity, liquidity position, and going-concern posture as disclosed in SEC filings.

Does MSTR have a going concern warning?

No current auditor going-concern warning is flagged in MSTR's SEC filings. Risk assessment is based on other filing-disclosed factors.

When did MSTR last file with the SEC?

MSTR's most recent SEC filing was a 8-K filed 2026-04-06. All filings are available on SEC EDGAR.

← MSTR Overview

8-KMay 5, 2026

MSTR — 8-K Filing

Track MSTR for Alerts

8-K Items Disclosed

Item 2.02 — Results of Operations and Financial Condition

Quarterly or annual earnings results released. Often paired with a press release as Exhibit 99.1.

Item 7.01 — Regulation FD Disclosure

Voluntarily-disclosed material information under Regulation FD (e.g., investor presentation, conference talk).

Item 9.01 — Financial Statements and Exhibits

Press releases, exhibits, and supporting documents attached to this filing.

MSTR Filing Excerpt

mstr-20260505UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549________________________________________________________FORM 8-K________________________________________________________CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): May 5, 2026________________________________________________________STRATEGY INC(Exact name of Registrant as Specified in Its Charter)________________________________________________________Delaware001-4250951-0323571(State or Other Jurisdictionof Incorporation)(Commission File Number)(IRS EmployerIdentification No.)1850 Towers Crescent PlazaTysons Corner, Virginia22182(Address of Principal Executive Offices)(Zip Code)Registrant’s Telephone Number, Including Area Code: 703 848-8600(Former Name or Former Address, if Changed Since Last Report)________________________________________________________Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR…

Current DredgeCap Risk Profile

Risk Score

6.2/10

ELEVATED

Dilution

7.5

Debt Toxicity

5.5

Going Concern

✓ Not flagged

The risk profile above reflects the latest cached DredgeCap analysis for MSTR. For the full filing-by-filing analyst report (red flags, primary risk driver, what moves the stock), open MSTR's company page.

What is a 8-K?

A current report disclosing a material event that occurred between regular reporting periods. Companies are required to file an 8-K within four business days of certain events including earnings releases, executive changes, acquisitions, debt obligations, restructurings, and material agreements. Each 8-K specifies one or more 'Items' identifying which event triggered the filing.

More on MSTR

The plain-language summary above is composed mechanically from the filing's reported numbers — no analysis or opinion. Form-type explainers and 8-K item descriptions are derived from SEC documentation. This page does not constitute investment advice. Always consult the original filing on SEC EDGAR for authoritative content, and consult a licensed financial advisor for investment decisions.